Logo
Logo

About Mirabegron (Alpha) API

Product
  • Therapeutic CategoryUrology

  • API Technology

    Synthetic

  • Dose Form

    ER Tablets

  • Dr Reddy's Development Status

    Available (Commercial)

  • Available Regulatory Filing

    USDMF, Brazil DMF, EUDMF, Canada DMF, Korea DMF, China DMF, CEP Submitted

作用机制

Mirabegron is an agonist of the human beta-3 adrenergic receptor (AR) as demonstrated by in vitro laboratory experiments using the cloned human beta-3 AR. Mirabegron relaxes the detrusor smooth muscle during the storage phase of the urinary bladder fill-void cycle by activation of beta-3 AR which increases bladder capacity. Although mirabegron showed very low intrinsic activity for cloned human beta-1 AR and beta-2 AR, results in humans indicate that beta-1 AR stimulation occurred at a mirabegron dose of 200 mg.

适应症

MYRBETRIQ is a beta-3 adrenergic agonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency.

MYRBETRIQ, in combination with the muscarinic antagonist solifenacin succinate, is indicated for the treatment of OAB with symptoms of urge urinary incontinence, urgency, and urinary frequency

Dr. Reddy's的专长

Dr. Reddy's总部位于印度海得拉巴,是全球领先的活性药物成分(API)供应商之一。 Dr. Reddy's的API业务是美国、欧洲、巴西、拉丁美洲、日本、中国、韩国和新兴市场的制药公司的首选合作伙伴。

Dr. Reddy's博士的API业务在过去30多年来在开发和制造复杂API(如类固醇,多肽,复杂长链分子和高效API(HPAPI /肿瘤药物))方面所建立的深厚技术优势中茁壮成长。 我们在知识产权和法规事务方面的实力可以帮助我们始终如一地达到并超越监管标准,从而为这一专业知识提供补充。 Dr. Reddy's博士 米拉贝隆 API是研发,知识产权和监管方面广泛专业知识的结果。

帮助我们的客户率先进入市场的关键组成部分是响应式供应链。 我们通过确保所有设施都高效运行并达到最新的质量,安全和生产率标准来实现这一目标。 业务和工厂之间的强大互联可以快速响应动态的市场变化,从而避免短缺并满足需求的突然激增。

 

Dr. Reddy's provides access to mirabegron API at competitive prices. We are a leading manufacturer of mirabegron, ensuring consistent quality and reliable supply for your pharmaceutical formulations. To know more about Mirabegron price please contact us at [email protected]

RFQ Form

Phone

Related Resources

Description not provided

FAQs

What is Mirabegron (Alpha) API used for?
  • Treats overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency

What are the benefits of Mirabegron (Alpha) API?
  • Increases bladder capacity
    Reduces urgency and frequency of urination
    Improves quality of life for OAB patients

What is the safety guide for Mirabegron (Alpha) API?
  • Monitor blood pressure regularly
    Avoid in patients with severe uncontrolled hypertension
    Use protective equipment when handling

Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.